Achieve Life Sciences (ACHV) Intangibles (2016 - 2026)
Achieve Life Sciences (ACHV) posted Intangibles of $696000.0 for Q1 2026, down 7.32% on a QoQ basis from $751000.0 in Q4 2025, and down 24.18% year-over-year from $918000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Intangibles (2016 - 2026) Analysis & Trends
Achieve Life Sciences' Intangibles history runs 11 years deep, the most recent figure standing at $696000.0 for Q1 2026.
- Quarterly Intangibles fell 24.18% year-over-year to $696000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $696000.0 (down 24.18% YoY) and the FY2025 annual result came in at $751000.0, down 22.9% from the prior year.
- Intangibles was $696000.0 for Q1 2026 at Achieve Life Sciences, down from $751000.0 in the prior quarter.
- Across five years, Intangibles topped out at $1.6 million in Q1 2022 and bottomed at $696000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Intangibles.
- Peak annual rise in Intangibles reached 12.33% in 2022, while the deepest fall reached 50.91% in 2022.
- Achieve Life Sciences' Intangibles stood at $1.4 million in 2022, then dropped by 15.59% to $1.2 million in 2023, then decreased by 18.63% to $974000.0 in 2024, then decreased by 22.9% to $751000.0 in 2025, then fell by 7.32% to $696000.0 in 2026.
- Business Quant data shows ACHV's Intangibles at $696000.0 in Q1 2026, $751000.0 in Q4 2025, and $807000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 55.80 Mn |
| 10 | Achieve Life Sciences | 330.17 Mn | 330.17 Mn | - | 696,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 696,000.00 |
| Dec 31, 2025 | 751,000.00 |
| Sep 30, 2025 | 807,000.00 |
| Jun 30, 2025 | 863,000.00 |
| Mar 31, 2025 | 918,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 3.12 Mn |